Chester Ramsey, Ph.D., director of medical physics at TCSC expects the time savings with Elekta VMAT, a new treatment that targets tumors with high doses of radiation while protecting healthy tissue, to be dramatic.
"With fixed-gantry IMRT delivery on other linear accelerators, it currently takes 7 to 15 minutes to treat most of our IMRT patients.
We estimate that VMAT treatment delivery times with Elekta Infinity will be reduced by at least 50 percent, without compromising treatment quality."
, clinicians and researchers began using single rotation, constant dose rate volume modulated arc therapy more than 10 years ago," explains Ramsey
"The added capabilities of Elekta Infinity, such as simultaneous control of gantry rotation speed, collimator rotation and variable dose rate will advance our cancer treatment program to a new level."
currently treats 100-150 patients per day at three locations.
expects to treat up to 40 patients each day with Elekta Infinity, about half of which will be VMAT treatments for prostate, head and neck, lung, esophagus and brain cancers.
says the new additions at TCSC
will provide patients with a higher standard of cancer care than ever before.
"The clinicians and researchers at TCSC
are extremely excited about our new relationship with Elekta